Schedule 13D ownership disclosure

Auris Medical Holding AG

Security class unavailable · CUSIP: H03579101

Event date: 2017-02-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,218,175
Percent of class
20.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-013542
Form type
SC 13D/A
Filer
Altamira Therapeutics Ltd.
CIK
CIK 1601936
Filed
Mar 09, 2017
Reporting period
Feb 15, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub